Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials

Cancer Chemother Pharmacol. 1979;3(2):97-101. doi: 10.1007/BF00254979.
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / toxicity*
  • Clinical Trials as Topic / methods*
  • Dogs
  • Drug Evaluation
  • Haplorhini
  • Humans
  • Mice
  • Retrospective Studies

Substances

  • Antineoplastic Agents